依夫加替莫治疗派姆单抗诱导的标准治疗难治性重症肌无力(P1-8.006)

{"title":"依夫加替莫治疗派姆单抗诱导的标准治疗难治性重症肌无力(P1-8.006)","authors":"Maryellen Campbell, A. Rodriguez-Hernandez, Zufe Rizvi, M. Swerdloff, E. Zakin, Svetlana Faktorovich","doi":"10.1212/wnl.0000000000202470","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":334567,"journal":{"name":"Sunday, April 23","volume":"2 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efgartigimod for Pembrolizumab-induced Myasthenia Gravis Refractory to Standard Therapy (P1-8.006)\",\"authors\":\"Maryellen Campbell, A. Rodriguez-Hernandez, Zufe Rizvi, M. Swerdloff, E. Zakin, Svetlana Faktorovich\",\"doi\":\"10.1212/wnl.0000000000202470\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":334567,\"journal\":{\"name\":\"Sunday, April 23\",\"volume\":\"2 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Sunday, April 23\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1212/wnl.0000000000202470\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sunday, April 23","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1212/wnl.0000000000202470","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}